It seems the OP days are back in Valorant as there are high chances Chambers mains will once again be able to teleport from ...

From FFXIV's base game to Marvel Rivals, plenty of FTP multiplayer games offer players exciting experiences without being ...

Jett in Valorant (Image via Riot Games ... It can be problematic if the opponents are rushing to the other side. Sage can be useful in certain scenarios on Ascent due to her ultimate, Resurrection.

Valorant’s head of anti-cheat has confirmed that a big change is in the pipeline as they’re cracking down on the rise of hackers. When Valorant first launched, Riot Games boasted about their ...

Valorant is cracking down on hackers by implementing ranked rollbacks to reverse progress or rank if a match is affected by cheaters. The new measures are designed to penalize cheaters and promote ...

Riot Games has revealed the new map rotation coming to VALORANT when patch 10.04 arrives, leaving some players perplexed. As we entered 2025, Riot Games ensured the map pool of VALORANT would remain ...

One of the things that Riot Games promised at the start of Valorant's Season 2025 is that the competitive map pool will receive changes more often than in previous years. Keeping their word, the ...

Legendary rockers Joan Jett and the Blackhearts are set to take the stage at the FireKeepers Event Center at 8 p.m. April 4. Tickets for this highly anticipated performance go on sale starting at ...

Roczen is off to a much better start in 2025 than in 2024. Last year, he barely cracked the top 10 and was more than one minute off the pace of the 2024 winner, Jett Lawrence. After the 2025 race, ...

Riot Games' first-person tactical shooting game (FPS) 'Valorant' unveiled a large-scale update and roadmap for the 2025 season on the 13th. The 2025 season consists of a total of six ActROs ...

Late last week, Biogen made an unsolicited offer to buy one of its partners, brain drug developer Sage Therapeutics. The two biotechnology companies have worked together over the past four years on a ...

Having witnessed a 90%-plus stock price slide during recent years, Sage Therapeutics’ leadership must decide whether now is the right time to accept a buyout offer. Biogen has offered to ...